Abstract
Human immunodeficiency virus type 1 (HIV-1) integrase is, in addition to reverse transcriptase and protease, an important enzymatic target for antiretroviral drug development. Integrase plays a critical role in the HIV-1 life cycle coordinating the integration of the reverse-transcribed viral DNA into the host genome. This integration step is the net result of two consecutive integrase-related processes. First, integrase removes a dinucleotide from the 3′ viral DNA ends in a process called 3′-processing. Next, in a process called strand transfer, the viral DNA is integrated into the host genomic DNA. Early on, biochemical assays have played a critical role in understanding the function of HIV-1 integrase and the discovery of small-molecule inhibitors. In this chapter we describe two biochemical assays to identify inhibitors of the 3′-processing and strand transfer process of HIV-1 integrase.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bushman FD, Engelman A, Palmer I et al (1993) Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc Natl Acad Sci USA 90(8):3428–3432
Asante-Appiah E, Skalka AM (1997) A metal-induced conformational change and activation of HIV-1 integrase. J Biol Chem 272(26):16196–16205
Jenkins TM, Engelman A, Ghirlando R et al (1996) A soluble active mutant of HIV-1 integrase: involvement of both the core and carboxyl-terminal domains in multimerization. J Biol Chem 271(13):7712–7718
Asante-Appiah E, Skalka AM (1997) Molecular mechanisms in retrovirus DNA integration. Antiviral Res 36(3):139–156
Engelman A, Mizuuchi K, Craigie R (1991) HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell 67(6):1211–1221
Esposito D, Craigie R (1999) HIV integrase structure and function. Adv Virus Res 52:319–333
Katz RA, Merkel G, Kulkosky J et al (1990) The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell 63(1):87–95
Bushman RD, Craigie R (1991) Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc Natl Acad Sci USA 88:1339–1343
Yi J, Asante-Appiah E, Skalka AM (1999) Divalent cations stimulate preferential recognition of a viral DNA end by HIV-1 integrase. Biochemistry 38:8458–8468
Deprez E, Tauc P, Leh H et al (2000) Oligomeric states of the HIV-1 integrase as measured by time-resolved fluorescence anisotropy. Biochemistry 39:9285–9294
He HQ, Ma XH, Liu B et al (2007) High-throughput real-time assay based on molecular beacons for HIV-1 integrase 3′-processing reaction. Acta Pharmacol Sin 28:811–817
Grobler JA, Stillmock KA, Hazuda D (2009) Scintillation proximity assays for mechanistic and pharmacological analyses of HIV-1 integration. Methods 47:249–253
John S, Fletcher TM III, Jonsson CB (2005) Development and application of a high-throughput screening assay for HIV-1 integrase enzyme activities. J Biomol Screen 10:606–614
Farnet CM, Wang B, Lipford JR et al (1996) Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules. Proc Natl Acad Sci USA 93:9742–9747
Hansen MS, Smith GJ III, Kafri T et al (1999) Integration complexes derived from HIV vectors for rapid assays in vitro. Nat Biotechnol 17:578–582
Wang Y, Klock H, Yin H et al (2005) Homogeneous high-throughput screening assays for HIV-1 integrase 3beta-processing, strand transfer activities. J Biomol Screen 10:456–462
Hazuda DJ, Felock P, Witmer M et al (2000) Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science 287:646–650
Hazuda DJ, Anthony NJ, Gomez RP et al (2004) A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase. Proc Natl Acad Sci USA 101:11233–11238
Hare S, Shun M-C, Gupta SS et al (2009) A novel co-crystal structure affords the design of gain-of-function lentiviral integrase mutants in the presence of modified PSIP1/LEDGF/p75. PLoS Pathog 5(1):e1000259. doi:10.1371/journal.ppat.1000259
Cherepanov P, Maertens G, Proost P et al (2003) HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J Biol Chem 278:372–381
Adachi A, Gendelman HE, Koenig S et al (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious clone. J Virol 59:284–291
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Clynhens, M. et al. (2013). Biochemical Screening Assays to Identify HIV-1 Integrase Inhibitors. In: Gong, E. (eds) Antiviral Methods and Protocols. Methods in Molecular Biology, vol 1030. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-484-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-62703-484-5_4
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-483-8
Online ISBN: 978-1-62703-484-5
eBook Packages: Springer Protocols